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False-positive radioiodine whole-body scan  
due to a renal cyst
Fałszywie dodani wynik scyntygrafii całego ciała z użyciem radiojodu 
spowodowany obecnością torbieli nerkowej
Adam Maciejewski, Rafał Czepczyński, Marek Ruchała
Department of Endocrinology, Metabolism, and Internal Medicine, Poznan University of Medical Science, Poznan, Poland
Abstract 
Patients affected by differentiated thyroid cancer are treated surgically and by ablative radioiodine therapy. A post-therapy whole-body 
scan allows detection of thyroid remnants or local and distant metastases, although false-positive findings may be observed. We report 
a case of a 75-year-old woman with follicular thyroid cancer, who underwent ablative radioiodine treatment. On post-therapy whole-
body scan, abnormal uptake in the left upper abdomen was found, although stimulated thyroglobulin level was not suggestive for distant 
metastases of differentiated thyroid carcinoma. Additional SPECT/CT acquisition revealed focal 131I uptake located at the posterolateral 
wall of the left kidney corresponding to a round lesion 47 mm in maximal diameter. In order to verify this finding abdominal ultrasound 
and abdominal contrast-enhanced CT were performed, confirming multiple renal cysts in the left kidney; the largest one was the site of 
abnormal radioiodine accumulation. Despite the high incidence of renal cysts, especially in the elderly, radioiodine uptake in renal cysts 
is extremely rare. Different hypotheses on the mechanism of radioiodine uptake in the cyst were proposed, among them active secretion 
by sodium-iodide symporter or other transporting proteins. We conclude that abnormal radioiodine uptake in renal cysts can be an ex-
ceptional finding mimicking a metastasis. (Endokrynol Pol 2018; 69 (6): 736–739)
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Streszczenie
U chorych ze zróżnicowanymi rakami tarczycy stosuje się leczenie chirurgiczne oraz ablację tarczycy radiojodem. Scyntygrafia kontro-
lna po leczeniu umożliwia wykrycie pozostałości tarczycy oraz przerzutów miejscowych lub odległych, chociaż obserwuje się czasami 
wyniki fałszywie dodatnie. W niniejszej pracy przedstawiono przypadek 75-letniej kobiety z rakiem pęcherzykowym tarczycy poddanej 
ablacji radiojodem. W scyntygrafii całego ciała wykonanej po leczeniu stwierdzono nieprawidłowy wychwyt w lewej górnej części jamy 
brzusznej, chociaż stężenie tyreoglobuliny po stymulacji TSH nie wskazywało na obecność przerzutów odległych zróżnicowanego 
raka tarczycy. Dodatkowe badanie SPECT/CT uwidoczniło ogniskowy wychwyt 131I zlokalizowany w tylno-bocznej ścianie nerki lewej 
odpowiadający okrągłej zmianie o maksymalnej średnicy 47 mm. W celu zweryfikowania tego wyniku wykonano USG jamy brzusznej 
oraz badanie tomograficzne jamy brzusznej z kontrastem. Badania te potwierdziły obecność mnogich torbieli w lewej nerce, z których 
największa odpowiadała miejscu patologicznej akumulacji radiojodu. Mimo że torbiele nerkowe występują często, zwłaszcza u osób 
w podeszłym wieku, wychwyt radiojodu w takich torbielach obserwuje się niezwykle rzadko. Przedstawiano różne hipotezy wyjaśniające 
mechanizm wychwytu radiojodu w torbielach nerkowych, w tym aktywne wydzielanie przez symporter sodowo-jodowy lub inne białka 
transportowe. Autorzy doszli do wniosku, że patologiczny wychwyt radiojodu w torbieli nerkowej może być wyjątkowym zjawiskiem 
imitującym zmianę przerzutową. (Endokrynol Pol 2018; 69 (6): 736–739)
Słowa kluczowe: rak pęcherzykowy tarczycy; torbiel nerkowa; radiojod; poterapeutyczna scyntygrafia całego ciała
Introduction
Patients diagnosed with differentiated thyroid cancer 
(DTC), both papillary and follicular type, are typi-
cally treated by surgical removal of the primary tumour 
(thyroidectomy or lobectomy) followed by radioiodine 
therapy (RIT) as an adjuvant therapy (excluding low-risk 
patients) [1]. Post-therapy 131I whole body scan (WBS) is 
performed a few days after RIT to detect thyroid rem-
nants and possible regional or distant metastases. WBS 
is considered accurate and highly sensitive; however, it 
should be interpreted cautiously because false-positive 
results and artefacts of different origin may occur. 
We present a case of a radioiodine-treated DTC pa-
tient. Post-therapy WBS showed abnormal radioiodine 
uptake in the left abdomen, corresponding to the renal 
location, which turned out to be a renal cyst. This type of 
artefact is rarely reported, and the mechanism of renal 
cysts radioiodine uptake is still uncertain.
Case report
A 75-year-old female was admitted to the Department of 
Endocrinology for assessment and ablative radioiodine 
treatment in the course of DTC. Total thyroidectomy 
was performed three months before, and minimally 
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lesion with dimensions 39 × 35 × 47 mm adjacent to 
the renal capsule. As the risk of metastasis to the kidney 
or perirenal tissue could not be excluded, the patient 
underwent abdominal ultrasound. Ultrasound imaging 
showed three anechoic structures of 44 mm, 14 mm, 
and 10 mm in maximum diameter localised in the left 
kidney, which were described as simple renal cysts, 
without any features of malignancy. 
Because renal cysts, which are relatively common 
in the general population, usually do not present with 
radioiodine uptake on WBS, CT of the abdomen was 
planned. Because of recent RIT, contrast-enhanced 
CT was performed four months after RIT. The study 
confirmed multiple simple cysts of the left kidney, with 
the largest one having a maximal diameter of 47 mm 
(Fig. 3). There were neither malignancy features nor 
other abnormalities found within the kidneys. 
After RIT the patient was referred to outpatient 
endocrine care, and reassessment on levothyroxine 
withdrawal is planned after one year. 
Discussion
Renal cysts are structures of the renal parenchyma filled 
with liquid or semisolid fluid enclosed by a smooth 
wall built of epithelial cells [2]. They can be classified 
into simple and complex. The incidence of simple renal 
cysts differs depending on age, population studied, and 
invasive follicular thyroid cancer in the right thyroid 
lobe was found on histopathology (maximal diameter 
of the tumour 3.5 cm) — stage pT3N0Mx. 
At the time of admission, four weeks after levothy-
roxine withdrawal, stimulated thyroglobulin (Tg) was 
5.80 ng/ml, while anti-Tg was 27 IU/ml (normal range: 
10–115) and TSH was 35.03 µU/ml (normal range: 
0.27–4.2). Neck ultrasonography showed an absence 
of thyroid remnants or metastatic lymph nodes. An 131I 
thyroid scan was performed before RIT, showing only 
minor focal remnants in the thyroid bed. The patient 
had no history of any significant comorbidities. Stan-
dard laboratory tests did not reveal any abnormalities 
(among them, serum creatinine and urea were found 
to be normal). 
The patient underwent RIT with the activity of 
120 mCi (4.4 GBq). WBS was performed 10 days af-
ter RIT, using an Infinia Hawkeye 4 gamma-camera 
(GE Healthcare) (Fig. 1). WBS showed some thyroid 
remnants within the thyroid bed, physiologic uptake 
areas, and abnormal radioiodine uptake in the left up-
per abdominal area, more pronounced at the posterior 
view. In order to verify the finding, single photon emis-
sion computed tomography/computed tomography 
(SPECT/CT) of the abdomen was obtained using the 
same gamma-camera (Fig. 2). The study confirmed 
abnormal 131I uptake located at the posterolateral wall 
of the left kidney. The focus corresponded to a round 
Figure 1. Post-therapeutic WBS showing uptake in thyroid bed and left upper abdomen, better seen in posterior view
Rycina 1. Poterapeutyczna scyntygrafia całego ciała pokazująca wychwyt w loży tarczycy i lewej górnej części jamy brzusznej, 
lepiej widoczny w projekcji bocznej
738
Radioiodine uptake in a renal cyst Adam Maciejewski et al.
O
P
IS
 P
R
Z
Y
PA
D
K
U
imaging techniques used, generally increasing with age 
[2]. They can be found in up to 60.6% of people over 80 
years of age [3]. Male preponderance is observed with 
male-to-female ratios from 1.4 to 2.8 [3]. Simple renal 
cysts are acquired, non-hereditary lesions, and usually 
no treatment is needed, unlike polycystic kidney dis-
ease. Because simple renal cysts are generally asymp-
tomatic, most of them are found incidentally during 
assessment for different reasons. Imaging techniques 
used in renal cysts assessment are abdomen ultrasound 
or CT, and rarely MRI. 
Campennì et al. reviewed the literature on this 
topic, finding nine cases of 131I uptake in renal cysts, 
and they reported another one [4]. Recently Yan-Xia 
et al. described abnormal 131I uptake in a patient with 
polycystic kidney disease [5]. Kidneys are the main 
organs of iodine excretion. Iodine is eliminated as 
an inorganic anion (mostly within two days after oral 
administration). However, a precise explanation of 
the mechanism of radioiodine uptake by renal cysts 
is lacking. Different hypotheses exist, one of them is 
a preserved communication between the cyst and 
collecting ducts, although it seems that typically renal 
cysts are detached from the tubule at an early stage of 
their development [6]. Another option is iodine pas-
sive diffusion from surrounding lymphatic or blood 
vessels. Finally, some authors advocate the third op-
tion, that iodine is actively secreted to the renal cyst 
lumen via transmembrane channels or co-transporting 
proteins [4]. 
Figure 2. SPECT/CT images that revealed focal uptake at the posterolateral part of the left kidney with size 39 × 35 × 47 mm
Rycina 2. Obrazy SPECT/CT uwidoczniły ognisko wychwytu w boczno-tylnej części lewej nerki o wymiarach 39 × 35 × 47 mm
Figure 3. Contrast-enhanced CT images showing multiple cysts of the left kidney
Rycina 3. Obrazy TK ze środkiem kontrastowym pokazujące liczne torbiele w lewej nerce
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These acquired cystic lesions are generally be-
lieved to arise from nephrons tubular diverticula. 
Moreover, the fact is that epithelial cells lining renal 
cysts resemble those of renal tubules [5]. That is why 
renal cyst epithelium is expected to exhibit secretory 
activity that probably varies depending on its origin 
(from different tubular segments). Different proteins 
involved in iodine transportation, known best due to 
their intrathyroidal function, have been found to be 
expressed in kidneys. One of them is Na+/I-symporter 
(NIS) — a transmembrane protein that mediates the ac-
tive transport of iodide into the thyrocytes. Functional 
NIS protein was detected in renal tubular cells in some 
studies, although with variable expression in different 
segments of the kidney [7, 8]. However, because the 
protein was shown to be localised at the apical surface 
of tubular cells, NIS would be responsible for iodide 
reabsorption from renal tubule lumen [9], so similarly in 
renal cysts it would lead to intraepithelial influx. Other 
transporting proteins known primarily from thyroid 
gland studies (where they are thought to be involved in 
iodide efflux to the follicular lumen), which transpired 
to be expressed in kidneys are pendrin [10], CFTR, and 
ClC-5. Nevertheless, their precise role in iodine balance 
maintenance is still discussed [11]. 
Post RIT uptake in the abdomen at planar scin-
tigraphy, similar to this presented herein, may be for 
different reasons. It could be an effect of physiologi-
cal gastrointestinal residual activity (e.g. stomach, 
colon), a result of artifacts (among them renal cysts), 
etc., but DTC metastases must also be taken into ac-
count. Although DTC metastases to kidneys are very 
rare, some cases were indeed reported. On autopsy, 
2.5 to 2.7% of all metastases to the kidney originated 
from thyroid carcinoma [12]. Some of them may be 
seen on WBS as a result of NIS expression [13]. That 
is why unilateral post-therapeutic uptake in kidneys 
should be assessed by an anatomical study, prefer-
entially CT scan.
Literature provides numerous examples of focal 
131I uptake that was first misdiagnosed as DTC metas-
tasis. Similarly to renal cysts, there are descriptions of 
other cysts, e.g. liver, nabothian, sebaceous, or ovarian 
cysts, mimicking DTC metastases [14]. False-positive up-
take on post-RIT scans may also result from non-thyroid 
neoplasms (both benign and malignant), retention of 
131I-containing secretions, or just contamination of the 
skin or clothing [14]. In most cases, a readily available 
technique of SPECT/CT is able to differentiate these 
findings. Conversely, in the case of non-iodine avid 
metastases, false-negative results are observed. In these 
rare situations, different techniques such as 18F-FDG 
PET/CT or somatostatin receptor scintigraphy may be 
helpful [15].
Conclusions
Post-RIT WBS is a reliable method for the detection of 
DTC remnants, recurrence, or metastases, although dif-
ferent reasons for false-positive results must be taken 
into account. Some of them are relatively common, 
while the others (such as simple renal cysts) are very 
rare, thus making differential diagnosis challenging. 
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